Back to results
US 2015/0105429 A1Published application
Benzyl sulfonamide derivatives as rorc modulators
AssigneeGenentech, Inc.
InventorsBenjamin Fauber, Olivier Rene
Life of this patent
Estimating the term…
Abstract
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, A, B, C, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.
Claims20
1-19. (canceled)
A compound of formula I:
- or pharmaceutically acceptable salts thereof,
- wherein:
- A is a group of formula:
- (a);
- (b);
- (c);
- or (d):
- B is a group of formula:
- (e);
- (f);
- (g) or (h):
- C is a group of formula:
- (i);
- (j);
- (k);
- or (m):
- m is 0 or 1;
- n is from 0 to 3;
- p is from 0 to 2;
- q is from 0 to 3;
- r is from 0 to 3;
- s is from 0 to 2;
- t is 0 or 1;
- u is from 0 to 3;
- R1 is:
- hydrogen;
- or C1-6alkyl;
- R2 is:
- hydrogen;
- or C1-6alkyl;
- R3 is:
- C1-6alkyl;
- C3-6cycloalkyl;
- C3-6cycloalkyl-C1-6alkyl;
- heterocyclyl;
- heterocyclyl-C1-6alkyl;
- phenyl-C1-6alkyl;
- or C1-6alkylsulfonyl, wherein the C1-6alkyl, C3-6cycloalkyl C3-6cycloalkyl-C1-6alkyl and phenyl-C1-6alkyl each may be optionally substituted one or more time with halo;
- R4 is:
- hydrogen;
- or C1-6alkyl;
- R5 is:
- hydrogen;
- or C1-6alkyl;
- R6 is:
- cyano;
- —(CH2)v—NRaRb;
- —(CH2)v—S(O)w—Rc;
- —(CH2)v—C(O)—NRaRb;
- —(CH2)v—S(O)w—NRaRb;
- —(CH2)v—NRd—C(O)—Rc;
- —(CH2)v—NRd—C(O)—NRaRb;
- or —(CH2)v—NRd—S(O)w—Rc, wherein:
- v is 0 or 1,
- w is from 0 to 2;
- Ra and Rb each independently is:
- hydrogen;
- or C1-6alkyl;
- Rc is:
- C1-6alkyl;
- C3-6cycloalkyl;
- or C3-6cycloalkyl-C1-6alkyl;
- and
- Rd is:
- hydrogen;
- or C1-6alkyl;
- each R7 is independently:
- C1-6alkyl;
- halo;
- C1-6alkoxy;
- cyano;
- halo-C1-6alkyl;
- hydroxy-C1-6alkyl;
- halo-C1-6alkoxy;
- or C1-6alkylsulfonyl;
- R8 is:
- C1-6alkyl;
- C3-6cycloalkyl;
- or C3-6cycloalkyl-C1-6alkyl;
- R9 is:
- hydrogen;
- or C1-6alkyl;
- R10 is:
- hydrogen;
- or C1-6alkyl;
- R11 is:
- hydrogen;
- hydroxy;
- cyano;
- —(CH2)n—NRaRb;
- —(CH2)n—S(O)v—Rc;
- —(CH2)n—C(O)—NRaRb;
- —(CH2)n—S(O)v—NRaRb;
- —(CH2)n—NRd—C(O)—Rc;
- —(CH2)v—NRd—C(O)—NRaRb;
- or —(CH2)n—NRd—S(O)v—Rc.
- each R12 is independently:
- C1-6alkyl;
- halo;
- C1-6alkoxy;
- cyano;
- halo-C1-6alkyl;
- halo-C1-6alkoxy;
- or C1-6alkylsulfonyl;
- each R13 is independently:
- C1-6alkyl;
- halo;
- C1-6alkoxy;
- cyano;
- halo-C1-6alkyl;
- halo-C1-6alkoxy;
- or C1-6alkylsulfonyl;
- each R14 is independently:
- C1-6alkyl;
- halo;
- C1-6alkoxy;
- cyano;
- halo-C1-6alkyl;
- halo-C1-6alkoxy;
- or C1-6alkylsulfonyl;
- R15 is:
- C1-6alkyl;
- C3-6cycloalkyl;
- or C3-6cycloalkyl-C1-6alkyl;
- R16 is:
- hydrogen;
- or C1-6alkyl;
- R17 is:
- hydrogen;
- or C1-6alkyl;
- each R18 is independently:
- C1-6alkyl;
- halo;
- C1-6alkoxy;
- cyano;
- halo-C1-6alkyl;
- halo-C1-6alkoxy;
- or C1-6alkylsulfonyl;
- and
- R19 is C1-6alkyl;
- provided that the compound is not N-isobutyl-N-[5-(3-methanesulfonyl-phenyl)-thiophen-2-ylmethyl]-C-phenyl-methanesulfonamide.
138 more elements
Dependencies are inferred from the claim text.